Welcome to our dedicated page for SCOTTS MIRACLE-GRO CO SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCOTTS MIRACLE-GRO CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCOTTS MIRACLE-GRO CO's regulatory disclosures and financial reporting.
Scotts Miracle-Gro director Katherine Hagedorn Littlefield reported receiving 3,271 Common Shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, indicating a grant or similar no-cost award.
After this transaction, she directly holds 10,211 Common Shares. She is also reported as having an indirect interest in 2,774,291 Common Shares held by Hagedorn Partnership, L.P., reflecting her proportionate interest and that of certain family members in the partnership’s holdings.
The Scotts Miracle-Gro Company director reports new share award. Director David C. Evans acquired 3,271 common shares of Scotts Miracle-Gro on January 30, 2026 in a transaction reported at $0 per share, indicating a grant or award rather than an open-market purchase. After this transaction, he beneficially owns 27,724 common shares, held directly.
Scotts Miracle-Gro director Austin Scott Miller acquired additional company shares. On 01/30/2026, he acquired 3,271 common shares at a price of $0 per share, increasing his direct holdings to 4,686 common shares.
Scotts Miracle-Gro director Nick Miaritis reported receiving 3,271 common shares on January 30, 2026, at a stated price of $0 per share. After this acquisition, he beneficially owned 6,231 common shares, held directly. The transaction was reported on a Form 4 insider trading report.
Scotts Miracle-Gro director Adam Hanft reported acquiring 3,271 common shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, which typically indicates a stock grant or award rather than an open-market purchase. Following this transaction, Hanft directly beneficially owns 44,682 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro President and COO Nathan Eric Baxter, who is also reported as a more than 10% owner, reported new equity awards and updated holdings. On January 30, 2026, he received a stock option for 59,298 common shares at an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036.
The filing also shows a transaction coded "J" for 96.284 common shares at a price of $51.93 per share, after which Baxter directly held 66,632.3988 common shares. In addition, 36,993 common shares are reported as indirectly owned through Hagedorn Partnership, L.P., where he is a general partner and may be deemed to have a proportionate beneficial interest under the SEC’s Rule 16a-1(a)(1).
Scotts Miracle-Gro director Peter E. Shumlin reported stock-based awards and conversions. On 01/30/2026, he acquired 4,049 common shares at $0, bringing his direct holdings to 30,328 shares. On 02/02/2026, 182 dividend equivalent rights were converted at $0 into 182 common shares, increasing his direct ownership to 30,510 shares.
The 182-share conversion came from dividend equivalent rights tied to a grant of 1,398 restricted stock units awarded on February 3, 2023, which vest on February 2, 2026. After this transaction, 1,028 dividend equivalent rights remain outstanding.
Scotts Miracle-Gro EVP, CFO & CAO Mark J. Scheiwer reported new equity awards and updated share holdings. On January 30, 2026, he received 29,649 stock options with an exercise price of $64.22 per common share, all held directly. The same day, he acquired 2.888 common shares at $51.93 each, bringing his directly held common shares to 15,288.741. He also reported indirect ownership of 493.482 common shares through a 401(k) plan.
Scotts Miracle-Gro director Stephen L. Johnson reported two stock awards. On January 30, 2026, he acquired 112 common shares of SCOTTS MIRACLE-GRO at $64.22 per share, bringing this holding to 27,520 shares.
On the same date, Johnson also received 3,271 common shares at a price of $0, described as Deferred Stock Units issued in lieu of a $7,188 retainer. After this grant, his directly held common shares increased to 30,791.
Scotts Miracle-Gro Chairman & CEO James Hagedorn, also a director and more than 10% owner, reported equity-related changes in his holdings. On January 30, 2026, he received a stock option grant for 142,315 common shares with an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036. He also acquired 38.513 common shares at $51.93 per share, bringing his directly held common shares to 104,112.9728. In addition, he reported indirect holdings of 31,533.64 common shares through a 401(k) plan and 997,910 common shares through Hagedorn Partnership, L.P., reflecting his proportionate and family pecuniary interests.